France · Delayed Price · Currency is EUR Guerbet Company Description
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions.
The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine; Elucirem, a macrocyclic gadolinium-based contrast agent; and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab.
It also provides digital solutions, such as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; and Patent Blue V, a blue dye.
Further, it offers Qitexio, a lipiodol resistant medical devices consisting of medical syringes and a stopcock; Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables, as well as HydraVision, a digital imaging system.
Guerbet SA was incorporated in 1926 and is headquartered in Villepinte, France.
| Country | France |
| Founded | 1926 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 2,905 |
| CEO | David Hale |
Contact Details
Address: 15, rue des Vanesses Villepinte, 93420 France | |
| Phone | 33 1 45 91 50 00 |
| Website | guerbet.com |
Stock Details
| Ticker Symbol | GBT |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0000032526 |
| SIC Code | 3844 |
Key Executives
| Name | Position |
|---|---|
| Philippe Bourrinet | Chief Pharmacist, Deputy Chief Executive Officer, Senior Vice President of Development, Medical and Regulatory Affairs and Deputy MD |
| David Hale | Chief Executive Officer, MD and GM |
| Jerome Estampes | Chief Financial Officer and Senior Vice President of Business Development and Licensing |
| Charlotte Bamiere | General Counsel and SVice President of Compliance |
| Christine Allard | Senior Vice President of Public Affairs and Corporate Communications |
| Eva Ohlsson | Senior Vice President of Human Resources |
| Jean-Francois Blanc | Senior Vice President of Interventional Imaging |
| Francois Nicolas | Senior Vice President of Research & Development, R&I and Chief Digital Officer |
| Valérie Brissart | Senior Vice President of Diagnostic Imaging |
| Gitte Hesselholt | Senior Vice President of Commercial Operations - Americas and EMEA |